Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
585.71
-13.05 (-2.18%)
At close: May 01, 2025, 3:19 PM
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
940
Upside
60.49
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Guggenheim | Buy | Maintains | 940 810 | 38.29% | May 1, 2025 | |
| Truist Securities | Buy | Maintains | 975 940 | 60.49% | Apr 30, 2025 | |
| Goldman Sachs | Buy | Maintains | 917 804 | 37.27% | Apr 30, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.